drugset

drugset / Trial / NCT02136927

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

NCT02136927 ↗

Phase 1 Terminated 33 enrolled Sun Pharma Advanced Research Company Limited

RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetic, bioequivalence study

Timeline

Start: 2014-08
Primary completion: 2016-04
Completion: 2016-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Reference1210	Unknown	—	Intravenous
Subject	SPARC1210	Unknown	—	Intravenous

Indications